NCT04180579View on ClinicalTrials.gov

Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Interventions
DEVICE

PAXMAN Scalp Cooler

Scalp cooling will occur with each dose of chemotherapy.

Trial Locations (1)

10021

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER